Aclaris Therapeutics, Inc.
About
4.55USD-0.02 -0.44%
Closed • Updated at 22:02 GMT+00:00Market Cap$635.47M
Volume1.18M
Beta0.98
RSI52.23
Gross Margin9.69%
Aclaris Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
May 8 2026
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
May 7 2026
Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update
Apr 28 2026
Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead Indicati...
Apr 27 2026
Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026
Recent Videos
Aclaris Therapeutics Inc. 2026 quarterly report
May 12, 2026
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
May 11, 2026
Cómo invertir en Aclaris Therapeutics Inc (ACRS) paso a paso
Mar 22, 2026
ACRS STOCK : BIG PRICE RECOVERY | ACLARIS THERAPEUTICS STOCK
Feb 20, 2026
Community Chat
Ask AI
Try asking